404

Not Found

Is this what you were looking for?

20http www boehringer ingelheim com corporate home home asp
By Jeffrey Bouley

Peteros and BI ink protein analysis agreement

Proteros Biostructures GmbH recently entered into a research collaboration with Ridgefield, Conn.-based Boehringer Ingelheim Pharmaceuticals in the field of protein crystallography, in an 18-month agreement under which Proteros will receive research funding fees and milestone payments for the generation and analyses of protein-ligand-structures of hits and evolved chemical entities from in-house Boehringer Ingelheim programs.
By Lloyd Dunlap

Going with the flow

Microfluidic device market expected to grow to $5.7 billion by 2018
By Amy Swinderman

All for one, one for all

Ten leading pharmas form nonprofit organization dedicated to alleviating clinical trial bottlenecks
By Kimberely Sirk

Worth weighting for?

Zealand Pharma and Boehringer Ingelheim to work on novel compounds to treat type 2 diabetes and obesity
By Jeffrey Bouley

Making trials less of a trial

Janssen Research & Development announces establishment of databank to enhance global cross-pharmaceutical clinical trial efforts

Run a Search

March 2024 Issue Front Cover

Latest Issue  

• Volume 20 • Issue 2 • March 2024

March 2024

March 2024 Issue